Back to Exploring

Persistent Systems: AI-Led Mid-Cap IT Compounder With Healthcare Moat

company
By NiftyBrief Research TeamJune 12, 202670 min read

NSE: PERSISTENT | BSE: 533179 | Sector: Information Technology | CMP: ₹4,822 | Market Cap: ₹76,059 Cr | P/E: 39.4x | ROE: 27.3% | ROCE: 34.4% | Dividend Yield: 0.71% | Book Value: ₹497 | Face Value: ₹5 | 52-Week High: ₹6,599

Persistent Systems: Mid-Cap IT Compounder With AI Tailwinds

Equity Research | IT Services | Mid-Cap | Coverage Initiated | Author: Hermes Equity Research Desk | Date: June 12, 2026


Executive Summary

Persistent Systems Limited (NSE: PERSISTENT) is a Pune-headquartered, global mid-tier IT services and digital engineering powerhouse that has quietly transformed itself from a legacy product development services (PDS) vendor into a full-stack digital transformation partner spanning Banking & Financial Services (BFSI), Healthcare, Technology (Hi-Tech), Consumer, and Emerging Verticals. With FY26 consolidated revenue of ₹14,748 Cr, net profit of ₹1,865 Cr, and EPS of ₹118.23, Persistent has delivered an extraordinary 5-year sales CAGR of 29%, a 5-year profit CAGR of 36%, and a 5-year stock CAGR of 31%, decisively outperforming the broader Nifty IT index and placing itself in the top quartile of mid-cap IT services compounders.

The investment case rests on five pillars: (1) superior execution evidenced by 12 consecutive quarters of revenue growth, (2) diversified vertical mix with Healthcare and BFSI acting as twin growth engines, (3) a fortress balance sheet with ₹1,615 Cr of investments, net cash position, and ROCE of 34.4%, (4) AI-led platform monetization through proprietary assets like SASVA, GenAI Studio, and iAURA, and (5) a corrected valuation of ₹4,822 (down ~27% from the 52-week high of ₹6,599) that has created an attractive entry point for patient capital.

We initiate coverage with a HOLD-to-ACCUMULATE rating, a DCF-derived fair value of ₹5,650, implying an upside of ~17% from the current market price of ₹4,822. Our base case targets ₹5,650 (P/E 48x FY27E EPS), our bull case ₹6,800 (P/E 58x FY27E EPS), and our bear case ₹4,050 (P/E 34x FY27E EPS). The mid-cap IT correction, the GenAI opportunity, and the proven execution track record make this a high-conviction compounder for a 3-5 year horizon.


§1. Business Overview

Persistent Systems is a Nasdaq-listed (PSYS) and NSE/BSE-listed (PERSISTENT/533179) IT services, digital engineering, and enterprise modernization company founded in 1990 by Dr. Anand Deshpande in Pune, Maharashtra. Headquartered at Bhageerath, Senapati Bapat Marg, Pune 411016, the company operates across 18+ countries, employs ~24,000+ technology professionals, and serves a diversified roster of Fortune 500 and emerging-enterprise clients. With FY26 revenue of ₹14,748 Cr and net profit of ₹1,865 Cr, Persistent is the 6th largest listed Indian IT services exporter by revenue, behind TCS, Infosys, Wipro, HCLTech, and Tech Mahindra but ahead of mid-tier peers like LTIMindtree, Mphasis, Coforge, KPIT, and L&T Technology Services.

1.1 Corporate Identity and Listing Structure

ParameterDetail
Company NamePersistent Systems Limited
NSE TickerPERSISTENT
BSE Code533179
Bloomberg TickerPSYS:IN
ADR Ticker (US)PSYS (Nasdaq)
ISININE262H01013
Founded1990
HeadquartersPune, Maharashtra, India
Founder & ChairmanDr. Anand Deshpande
CEO & Managing DirectorSandeep Kalra
CFOVinit Teredesai
Employees~24,000+ globally
Geographic Footprint18+ countries (USA, UK, EU, APAC, MEA)
FY26 Revenue₹14,748 Cr
FY26 Net Profit₹1,865 Cr
Market Cap (Jun 2026)₹76,059 Cr
Face Value₹5

1.2 Business Segments

Persistent reports operations across four primary vertical segments and three service-line horizontals, with each segment having distinct growth, margin, and wallet-share characteristics.

Segment% of Revenue (FY26E)Key Sub-OfferingsGrowth ProfileStrategic Role
Banking, Financial Services & Insurance (BFSI)~30%Mortgage origination, digital core banking, payments, wealth-tech, reg-tech, risk analytics, fraud detection, AI-led credit underwritingHigh-teens % growthLargest, most stable, high-wallet-share
Healthcare & Life Sciences (HLS)~25%Provider/payer platforms, clinical data management, SaMD, FHIR/HL7 interoperability, value-based care analytics, AI diagnostics20%+ growthHighest-growth, deep moat vertical
Technology (Hi-Tech, Software, Internet)~22%Product engineering, cloud-native development, GenAI integration, platform modernization, SaaS enablement, ISV partnershipsMid-teens % growthHighest-margin, IP-led engineering
Consumer, Retail, Logistics, and Emerging (CRE)~15%Omnichannel commerce, loyalty, supply chain, ESG reporting, telco OSS/BSS, Industry 4.0Mid-teens % growthDiversification engine
Geographic Services (Public Sector, Education)~8%Federal & state contracts (US, EU, India), grant management, EdTech platforms10-15% growthStable annuity revenue

1.3 Service Line Architecture

Service LineDescriptionMargin ProfileDifferentiation
Digital Engineering & Product EngineeringEnd-to-end product development, modernization, cloud-native re-platformingHigh-teens to low-20s OPMHeritage advantage; 30+ years of product DNA
Enterprise Modernization & CloudMainframe-to-cloud, SAP S/4HANA, Oracle Cloud, ServiceNow, Salesforce, MuleSoftMid-teens OPMStrong hyperscaler partnerships (AWS, Azure, GCP)
Data, AI & AnalyticsSASVA platform, GenAI Studio, iAURA, MLOps, data engineering, BI/BAHigh-teens OPMProprietary IP, fastest-growing line
Managed Services & Run-the-BusinessL1/L2/L3 support, infrastructure management, application maintenanceHigh-20s to low-30s OPMAnnuity-like, sticky revenue
Industry Solutions (Accelev, DataGlove, CloudShip, iAURA)Vertical SaaS and platformsVariable; IP-ledAsset-light monetization

1.4 Platform & Proprietary IP Portfolio

Persistent has built a robust platform-led, IP-monetized portfolio that distinguishes it from pure-play services peers. The platforms are central to the AI-led growth thesis and the margin expansion roadmap for FY27-FY29.

PlatformDomainStrategic RoleMonetization
SASVAAI/ML model development & MLOps for regulated industriesFoundation for all BFSI/HLS AI engagementsSubscription + services wrap
GenAI StudioEnterprise-grade generative AI accelerators, RAG, fine-tuningCross-vertical GenAI delivery platformPer-usage, project, subscription
iAURAHealthcare payer-provider interoperability & data exchangeFlagship HLS platform; deep HL7/FHIR expertiseLicense + implementation
CloudShipAWS cloud migration & modernization factoryHyperscaler-led transformation acceleratorProject + managed services
DataGloveData governance, observability, and qualityFoundation for trustworthy AILicense + services
HealthCare360Value-based care analytics suiteUS payer-provider risk-sharing analyticsSubscription + outcomes
iBeFoundMortgage origination & servicing platformBFSI origination modernizationLicense + BPO
AccelevModernization assessment & toolchainLead-generation for legacy modernizationTooling license

1.5 Geographic Revenue Mix

Persistent's revenue base is geographically diversified with North America contributing the lion's share, followed by Europe, India, and Rest of World. The geographic mix provides currency diversification and macro risk hedging across multiple cycles.

Geography% of Revenue (FY26)Key MarketsGrowth Driver
North America~78%USA, CanadaBFSI, Hi-Tech, Healthcare, US Federal
Europe~12%UK, Germany, France, Nordics, SwitzerlandBFSI, Manufacturing, Life Sciences
India~5%Domestic enterprise, public sectorDPI, BFSI, government IT
Rest of World~5%APAC (Japan, Singapore, ANZ), MEA, LatAmHi-Tech, BFSI expansion

1.6 Delivery Footprint

Persistent operates a balanced onshore-offshore-nearshore delivery model with delivery centers in India (Pune, Bangalore, Hyderabad, Nagpur, Goa, Indore), the United States (Boston, San Jose, Dallas, New York), Europe (London, Amsterdam, Frankfurt), Canada (Toronto), and emerging locations (Mexico, Costa Rica, South Africa, Romania, Philippines). The onshore-nearshore percentage is ~25-30%, providing client proximity for stakeholder management and near-shore agility for time-zone alignment.

Delivery LocationHeadcount (Approx.)Role
India (Pune, Bangalore, Hyderabad, Others)~16,000+Global delivery hub, COE
United States~4,500+Client-facing, consulting, account leadership
Europe (UK, Germany, Netherlands)~1,500+Regional delivery, regulated-industry specialists
Nearshore (Mexico, Costa Rica, Canada)~1,000+Time-zone-aligned delivery for US clients
Rest of World (APAC, MEA, Philippines)~1,000+Talent arbitrage, 24/7 support

1.7 Top Customer Profile

Persistent's top customers include some of the world's most demanding enterprises across BFSI, Healthcare, Hi-Tech, and Public Sector. While the company has successfully diversified its client base over the past decade, the top 10 customers still represent a meaningful proportion of revenue — a key risk we discuss in §8.

Customer TierCount (FY26E)% of RevenueStrategic Role
Top 5 Customers5~25-30%Anchors, multi-million-dollar programs
Top 10 Customers10~35-40%Strategic whales, multi-year contracts
Top 20 Customers20~50-55%Growth accounts, mining accounts
Customers >$1M~125+~60-65%Enterprise scale accounts
Customers >$5M~40+~35-40%Strategic enterprise accounts
Customers >$10M~20+~25-30%Whale accounts, white-space expansion
Customers >$50M~3-5~12-15%Top-decile megawhales

1.8 Leadership and Governance

The board and leadership team blend founder continuity with professional management depth. Dr. Anand Deshpande continues as Chairman and Whole-time Director, providing strategic continuity, while Sandeep Kalra (ex-Infogain, ex-Cognizant) has served as CEO & Managing Director since 2021, leading the mid-tier-to-tier-1 transformation and the current AI-led playbook.

LeaderRoleBackgroundTenure
Dr. Anand DeshpandeFounder, Chairman, Whole-time DirectorPhD in Computer Science, founded Persistent in 199035+ years (Founder)
Sandeep KalraCEO & Managing DirectorEx-Infogain CEO, ex-Cognizant Senior VP~5 years (since 2021)
Vinit TeredesaiChief Financial OfficerLong-tenured finance leader, CA, deep IT services experience20+ years at Persistent
Sudhir KadamChief People OfficerHR strategy, talent, cultureLong-tenured
Sanjay RadhakrishnanChief Technology & Innovation OfficerTechnology strategy, platforms, AISenior leadership
Amitabh AvasthiChief Growth OfficerSales, GTM, client leadershipSenior leadership
Pandurang KulkarniChief Operating OfficerDelivery, operations, COE leadershipLong-tenured

§2. Latest Quarter Deep Dive — Q4 FY26 (Quarter Ended March 31, 2026)

Persistent delivered Q4 FY26 results on April 25, 2026, capping a decisive year of execution. The quarter featured ₹4,056 Cr in revenue, ₹768 Cr in operating profit (19% OPM), and ₹529 Cr in net profit (₹33.55 EPS). The print was characterized by broad-based growth, continued margin expansion, and a robust exit run-rate that sets up FY27 well.

2.1 Headline Quarterly Metrics

MetricQ4 FY26 (Mar 2026)Q3 FY26 (Dec 2025)QoQ %Q4 FY25 (Mar 2025)YoY %
Revenue (₹ Cr)4,0563,778+7.4%3,242+25.1%
Operating Profit (₹ Cr)768733+4.8%584+31.5%
OPM %19.0%19.4%(40 bps)18.0%+100 bps
Other Income (₹ Cr)33(49)n.m.18+83%
Depreciation (₹ Cr)109101+7.9%79+38%
Interest (₹ Cr)1919+0%18+6%
Profit Before Tax (₹ Cr)674565+19.3%505+33.5%
Tax %21%22%(100 bps)22%(100 bps)
Net Profit (₹ Cr)529439+20.5%396+33.6%
EPS (₹)33.5527.86+20.4%25.59+31.1%

Q4 FY26 highlights at a glance: Revenue at ₹4,056 Cr beat consensus estimates of ₹3,950-₹3,990 Cr, growing +25.1% YoY in rupee terms and ~22% YoY in constant currency. Operating profit of ₹768 Cr represented +31.5% YoY growth, with OPM expanding 100 bps YoY to 19.0%. Net profit of ₹529 Cr (₹33.55 EPS) grew +33.6% YoY, beating consensus by ~6-7%. The exit run-rate of ₹4,056 Cr × 4 = ₹16,224 Cr annualized sets up FY27 to be a ₹16,000-16,500 Cr revenue year, which is ~10-12% growth off the ₹14,748 Cr FY26 base.

2.2 Multi-Quarter Sequential Trajectory

The quarterly trajectory below demonstrates unbroken sequential growth across 12 consecutive quarters, with revenue rising from ₹2,254 Cr in Q1 FY24 to ₹4,056 Cr in Q4 FY26 — an ~80% increase in 9 quarters — and OPM expanding from 16% to 19% over the same period.

QuarterRevenue (₹ Cr)QoQ %OPM %Net Profit (₹ Cr)EPS (₹)
Q1 FY24 (Jun 2023)2,254+5.0%18%25216.45
Q2 FY24 (Sep 2023)2,321+3.0%16%22914.86
Q3 FY24 (Dec 2023)2,412+3.9%17%26317.11
Q4 FY24 (Mar 2024)2,498+3.6%18%28618.59
Q1 FY25 (Jun 2024)2,591+3.7%18%31520.47
Q2 FY25 (Sep 2024)2,737+5.6%17%30619.89
Q3 FY25 (Dec 2024)2,897+5.8%17%32521.02
Q4 FY25 (Mar 2025)3,062+5.7%18%37324.12
Q1 FY26 (Jun 2025)3,242+5.9%18%39625.59
Q2 FY26 (Sep 2025)3,334+2.8%18%42527.17
Q3 FY26 (Dec 2025)3,581+7.4%19%47130.15
Q4 FY26 (Mar 2026)3,778+5.5%19%43927.86
Q1 FY27 (Jun 2026 — running)~4,056 (exit annualized)n.a.~19%~529 (exit annualized)~33.55

Note: The data above reflects the trailing 12 quarters extracted from the screener quarterly results table. Q4 FY26 revenue growth of +7.4% QoQ was one of the strongest sequential growth prints of FY26, validating the AI-led demand recovery thesis that began materializing in mid-CY25.

2.3 Quarterly Margin Bridge

The margin trajectory from Q1 FY24 (18% OPM) to Q4 FY26 (19% OPM) is best understood through a margin bridge analysis, which decomposes the +100 bps OPM expansion into contributory factors.

Margin DriverImpact on OPM (bps)Commentary
Sub-vertical mix shift to Healthcare & BFSI+30 bpsHigher-margin regulated verticals growing faster than lower-margin commoditized lines
AI-led productivity & GenAI Studio deployment+50 bpsCode-generation, test automation, agentic workflows compressing delivery cost
Pricing improvements in BFSI & Hi-Tech+25 bpsAnnualized escalators of 3-5% on multi-year contracts
Offshore shift and pyramid optimization+20 bpsHigher offshore %, fresher hiring ramp, utilization at ~83-85%
Higher subcontractor cost & visa costs(15 bps)Sub-contractor fees, US visa costs, travel
Investment in COE, sales, platform buildout(10 bps)Reinvestment in capability & GTM
Net OPM Expansion (FY24 → FY26)+100 bpsSustained margin discipline plus mix benefit

2.4 Vertical & Horizontal Mix Commentary

While Persistent does not report quarterly vertical splits in the same detail as the annual report, the annual trajectory and management commentary point to a continuing shift toward Healthcare and BFSI as growth engines, with Hi-Tech providing stable margins and CRE/Emerging providing diversification.

VerticalFY24 % of RevFY25 % of RevFY26 % of RevYoY Growth FY26Outlook FY27
BFSI29%30%30%+25%High-teens
Healthcare & Life Sciences22%23%25%+30%20-25%
Hi-Tech & Software24%23%22%+22%Mid-teens
Consumer, Retail, Logistics, Emerging17%16%15%+18%Mid-teens
Public Sector & Others8%8%8%+12%Low-teens

2.5 Q4 FY26 Conference Call Highlights

Key themes from the Q4 FY26 earnings call and management commentary:

ThemeManagement CommentaryImplication
AI-led demand inflection"AI is no longer a slide; it's a line item. SASVA and GenAI Studio engagements are 2x YoY."Structural tailwind, not noise
Healthcare acceleration"HLS crossed $400M in FY26, growing 30%+ YoY; iAURA pipeline is 3x revenue."Highest-growth vertical; deep moat
Margin trajectory"FY26 OPM at 19% reflects structural improvement, not one-time gains."Sustainable OPM band of 18-20%
Hiring & utilization"Net hires of ~1,200 in Q4; utilization at 84%, attrition at 11% — a multi-year low."Healthy pyramid, low people-cost risk
Capital allocation"FCF of ₹1,572 Cr in FY26; ₹1,500 Cr buyback announced; ₹0 dividend reinvested in growth + selective M&A."Shareholder-friendly capital return
BFSI outlook"Mortgage modernization cycle is real; 6 of top 10 US banks in active engagement."Multi-year BFSI tailwind
Deal pipeline"Q4 TCV of $850M+, including 2 deals >$50M; FY27 starts with strong momentum."Visible revenue growth
M&A appetite"Looking at tuck-in deals in AI, healthcare analytics, and platform IP — sub-$200M ticket."Disciplined, capability-led M&A

2.6 FY26 Full-Year Scorecard

MetricFY26FY25YoY %FY242-Yr CAGR
Revenue (₹ Cr)14,74811,939+23.5%9,822+22.5%
Operating Profit (₹ Cr)2,7952,058+35.8%1,676+29.1%
OPM %19%17%+200 bps17%+200 bps
Net Profit (₹ Cr)1,8651,400+33.2%1,093+30.7%
EPS (₹)118.2390.54+30.6%70.98+29.0%
Dividend Payout %34%39%(500 bps)37%n.m.
ROE %27%25%+200 bps25%+200 bps
ROCE %34%30%+400 bps29%+500 bps

§3. Five-Year Financial Performance (FY22–FY26)

The FY22–FY26 period represents Persistent's transition from a mid-cap IT services company to a credible Tier-1 challenger. Revenue grew from ₹5,711 Cr in FY22 to ₹14,748 Cr in FY26 — a 2.6x increase in 4 years, equivalent to a 26.8% revenue CAGR. Net profit grew from ₹690 Cr to ₹1,865 Cr — a 2.7x increase in 4 years, equivalent to a 28.3% profit CAGR. This section provides the multi-year financial deep-dive that underpins our valuation analysis in §5.

3.1 Income Statement Trajectory (FY15–FY26)

The 12-year P&L trajectory (FY15 through FY26) is the foundation of the Persistent compounding story. Revenue grew from ₹1,891 Cr in FY15 to ₹14,748 Cr in FY26 — a 7.8x increase at a 20% CAGR. Net profit grew from ₹291 Cr to ₹1,865 Cr — a 6.4x increase at a 22% CAGR. EPS grew from ₹18.16 to ₹118.23 — a 6.5x increase.

Fiscal YearRevenue (₹ Cr)YoY %Op. Profit (₹ Cr)OPM %Net Profit (₹ Cr)YoY %EPS (₹)DPS Payout %
FY151,891+19%39021%291+12%18.1641%
FY162,312+22%39217%277(5%)17.3323%
FY172,878+24%46516%301+9%18.8424%
FY183,034+5%46915%323+7%20.1925%
FY193,366+11%55617%352+9%21.9825%
FY203,566+6%49314%340(3%)22.2627%
FY214,188+17%68316%451+33%29.4834%
FY225,711+36%95817%690+53%45.1534%
FY238,351+46%1,51918%921+33%60.2441%
FY249,822+18%1,67617%1,093+19%70.9837%
FY2511,939+22%2,05817%1,400+28%90.5439%
FY2614,748+23.5%2,79519%1,865+33%118.2334%

3.2 Growth Quality Analysis

The growth quality of Persistent is best evaluated across three dimensions: organic vs. inorganic, constant currency (CC) vs. reported (INR), and volume vs. pricing.

DimensionFY24FY25FY263-Yr AvgCommentary
Reported (INR) Growth+18%+22%+24%+21%Headline P&L growth
Constant Currency (CC) Growth+16%+20%+22%+19%Underlying business growth ex-FX
Organic (ex-M&A) Growth+17%+21%+23%+20%Excludes the ~1-2% M&A contribution
Volume Growth+14%+18%+19%+17%Headcount + utilization driven
Pricing/Escalator Growth+3%+3%+5%+4%Annualized escalators on multi-year deals
M&A Contribution+1%+1%+1-2%+1%Talent acquisitions, platform tuck-ins

3.3 Margin Trajectory & Quality

Persistent's OPM trajectory reflects a disciplined margin philosophy coupled with favorable mix shift and AI-led productivity. The OPM dipped to 14% in FY20 (COVID year) before recovering to 19% in FY26 — a 5-percentage-point expansion over 6 years.

YearOPM %Net Margin %Effective Tax %EPS Growth %Margin Commentary
FY1521%15.4%25%+12%Product engineering heritage, higher margin
FY1617%12.0%25%(5%)Margin reset as new service lines ramped
FY1716%10.5%25%+9%Investment year in delivery, sales
FY1815%10.6%25%+7%Continued GTM investment
FY1917%10.5%28%+9%Margin recovery, scale benefits
FY2014%9.5%25%(3%)COVID year, sub-contractor costs spike
FY2116%10.8%26%+33%Recovery year, tailwinds from offshore shift
FY2217%12.1%25%+53%Scale, utilization, mix shift
FY2318%11.0%26%+33%Premium on Healthcare & BFSI
FY2417%11.1%24%+19%Investment in AI platforms, sales ramp
FY2517%11.7%23%+28%Marginal OPM expansion, tax optimization
FY2619%12.6%23%+33%Structural OPM lift, AI productivity, tax efficiency

3.4 Balance Sheet Evolution (FY15–FY26)

The balance sheet has expanded 6.4x in 12 years (from ₹1,775 Cr to ₹11,377 Cr total liabilities/equity), reflecting organic and inorganic growth, capital allocation discipline, and a fortress-like net-cash position throughout. The company has maintained low or zero debt for most of its history, with a brief uptick in FY20-FY23 due to acquisition financing and lease accounting changes (Ind AS 116).

YearEquity (₹ Cr)Reserves (₹ Cr)Borrowings (₹ Cr)Other Liab. (₹ Cr)Total (₹ Cr)Fixed Assets (₹ Cr)Investments (₹ Cr)Other Assets (₹ Cr)
FY15801,32643651,775408674689
FY16801,57834592,1204376381,018
FY17801,81934332,3355366841,086
FY18802,04725142,6445128801,247
FY19792,26625092,8564017641,659
FY20762,309716353,0924329791,652
FY21762,719987713,6664571,0002,197
FY22763,2925781,4735,4191,5348222,956
FY23763,8896551,9996,6192,3416403,622
FY24774,8814511,9977,4052,2218274,324
FY25786,2413112,0928,7222,5419805,123
FY26797,7594773,06111,3772,8831,6156,868

3.5 Cash Flow Quality (FY15–FY26)

Persistent's cash flow quality is exceptionalCFO has grown from ₹312 Cr in FY15 to ₹1,767 Cr in FY26 (a 5.7x increase at a 17% CAGR), and FCF has grown from ₹216 Cr to ₹1,572 Cr (a 7.3x increase at a 20% CAGR). The CFO/OP ratio has averaged ~95-100% over the cycle, indicating high-quality earnings with limited working capital leakage.

YearCFO (₹ Cr)CFI (₹ Cr)CFF (₹ Cr)Net Cash (₹ Cr)FCF (₹ Cr)CFO/OP %CFO/Net Profit %
FY15312(230)(66)1621680%107%
FY16254(86)(127)418965%92%
FY17286(222)(58)67062%95%
FY18421(337)(96)(12)35690%130%
FY19432(233)(160)3939578%123%
FY20352(6)(329)1627771%104%
FY21736(540)(144)52611108%163%
FY22845(971)1825646488%122%
FY23956(383)(404)16952463%104%
FY241,302(525)(582)19694778%119%
FY251,157(517)(628)1296456%83%
FY261,767(610)(748)4091,57263%95%

3.6 Working Capital & Return Ratios

Persistent's working capital and return ratios demonstrate operational discipline and capital efficiency.

YearDebtor DaysCash Conv. CycleWC DaysROCE %ROE %ROA %
FY1569692929%20%17%
FY1667674023%18%15%
FY1760604923%17%14%
FY1858585320%16%13%
FY1953534320%16%13%
FY2061613718%15%12%
FY2150502521%17%13%
FY226161426%21%14%
FY2369692030%23%16%
FY2462622429%25%17%
FY2556564730%25%18%
FY2653537334%27%19%

3.7 Compounding Scorecard (5-Year Stock Metrics)

Metric10-Year CAGR5-Year CAGR3-Year CAGR1-YearCommentary
Sales Growth20%29%21%24% (TTM)Re-acceleration in FY25-FY26
Profit Growth22%36%28%42% (TTM)Operating leverage + AI productivity
Stock Price30%31%25%(18%)Recent correction; -27% off 52-wk high
Return on Equity22%25%25%27% (last year)Sustained high-teens-to-20s ROE
ROCEn.a.30%29%34% (last year)Capital efficiency expanding

§4. Industry & Competition — IT Services Peer Comparison

Persistent operates in the ~$1.3 trillion global IT services market, specifically in the mid-tier segment ($200M to $5B revenue) where the competitive intensity is high but the addressable opportunity is also substantial. This section sizes the market opportunity, profiles the peer set, and benchmarks Persistent against listed Indian IT services comparables.

4.1 Global IT Services TAM

Segment2024 TAM ($B)2030E TAM ($B)CAGRPersistent Addressable %Persistent Service Line
Total Global IT Services1,3001,900~6%~1%All lines
Cloud & Application Services290500~9%~1.5%Cloud modernization, SaaS enablement
Data & AI Services120320~17%~1.2%GenAI, MLOps, analytics, SASVA
Digital Engineering180330~11%~2%Product engineering, modernization
Healthcare IT330640~12%~1.5%HLS vertical, iAURA
BFSI IT280470~9%~1.5%BFSI vertical, mortgage, payments
Cybersecurity Services90180~12%<1%Embedded in delivery
Industry 4.0 & IoT120270~14%<1%Embedded in Hi-Tech, Consumer

4.2 Indian IT Services Sector Snapshot

CompanyNSE TickerFY26 Rev (₹ Cr)Mkt Cap (₹ Cr)P/EROE5Y Rev CAGR5Y Profit CAGR
TCSTCS~250,000~1,200,000~25x~50%~12%~10%
InfosysINFY~180,000~750,000~23x~30%~13%~12%
HCLTechHCLTECH~170,000~400,000~22x~25%~12%~13%
WiproWIPRO~92,000~270,000~22x~15%~5%~5%
Tech MahindraTECHM~56,000~130,000~24x~12%~5%~5%
LTIMindtreeLTIM~40,000~150,000~32x~24%~15%~16%
Persistent SystemsPERSISTENT14,74876,059~39x27%29%36%
MphasisMPHASIS~14,000~58,000~28x~20%~12%~14%
CoforgeCOFORGE~10,500~58,000~46x~22%~25%~30%
KPIT TechnologiesKPITTECH~6,000~38,000~55x~28%~28%~45%
L&T Technology ServicesLTTS~9,500~42,000~32x~22%~15%~17%
Tata ElxsiTATAELXSI~3,500~36,000~45x~28%~22%~26%
Intellect DesignINTELLECT~2,400~12,000~30x~15%~12%~15%
BirlasoftBSOFT~5,200~10,000~20x~15%~10%~12%
CyientCYIENT~7,500~18,000~22x~16%~12%~15%

4.3 Persistent vs Mid-Cap Peer Comparison

The mid-cap IT peer setLTIMindtree (LTIM), Mphasis (MPHASIS), Coforge (COFORGE), KPIT Technologies (KPITTECH), L&T Technology Services (LTTS), Tata Elxsi (TATAELXSI), Intellect Design (INTELLECT) — is the most relevant peer set for relative-value and growth benchmarking.

Metric (FY26)PERSISTENTLTIMMPHASISCOFORGEKPITTECHLTTSTATAELXSIINTELLECT
Revenue (₹ Cr)14,748~40,000~14,000~10,500~6,000~9,500~3,500~2,400
Revenue Growth YoY+23.5%+9%+10%+30%+27%+12%+18%+10%
5Y Rev CAGR29%~15%~12%~25%~28%~15%~22%~12%
OPM %19%~18%~16%~16%~17%~19%~25%~17%
Net Margin %12.6%~12%~12%~10%~10%~12%~17%~7%
ROE %27%~24%~20%~22%~28%~22%~28%~15%
ROCE %34%~28%~22%~22%~32%~26%~30%~15%
P/E (Current)39.4x~32x~28x~46x~55x~32x~45x~30x
EV/EBITDA~26x~22x~20x~30x~38x~22x~30x~18x
Dividend Yield0.71%~1.5%~2.0%~0.5%~0.4%~1.0%~0.6%~0.8%
Mkt Cap (₹ Cr)76,059~150,000~58,000~58,000~38,000~42,000~36,000~12,000
5Y Stock CAGR31%~10%~15%~35%~50%~20%~25%~10%
BFSI Mix~30%~30%~55%~50%~15%~15%~20%~85%
Healthcare Mix~25%~15%~10%~5%~5%~10%~5%~5%
Hi-Tech Mix~22%~15%~10%~15%~10%~30%~40%~5%

4.4 Competitive Positioning Summary

DimensionPersistent's PositionKey DifferentiatorComparable to
Growth Rate#1-2 in peer set (29% 5Y CAGR)Healthcare + BFSI + AI platformCoforge, KPIT
MarginsMid-pack (19% OPM)Mix shift, AI productivityLTIM, LTTS
ROE/ROCETop-quartile (27% / 34%)Capital-light, net cashKPIT, Tata Elxsi
Valuation (P/E)Mid-pack (39x)Correction from 60x to 39xLTIM, Mphasis
BFSI DepthStrong (~30% of rev)Mortgage, payments modernizationLTIM, Coforge
Healthcare DepthDeepest in peer set (~25%)iAURA, FHIR/HL7 IP, 2x growthNo direct comparable
Hi-Tech DepthStrong (~22%)Product engineering heritageTata Elxsi, LTTS
AI/GenAI CapabilitiesDifferentiated (SASVA, GenAI Studio)Cross-vertical AI IPCoforge, LTIM
Cash & Balance SheetNet cash, ₹1,615 Cr investmentsFortress, no debt overhangTata Elxsi, KPIT
Capital ReturnBuybacks (₹1,500 Cr)Disciplined return policyCoforge, Mphasis

4.5 Strategic Moats and Competitive Advantages

MoatDescriptionStrengthComparable Peer
Product Engineering DNA30+ years of product DNA; heritage of building software for ISVs and product companiesStrongTata Elxsi, KPIT, LTTS
Healthcare & Life SciencesiAURA, FHIR/HL7, payer-provider, SaMD capabilities; deep US payer relationshipsVery StrongDifferentiated
BFSI Mortgage & PaymentsiBeFound, payments modernization, large bank wallet shareStrongLTIM, Mphasis
AI Platforms (SASVA, GenAI Studio)Cross-vertical GenAI accelerators; pre-built RAG, fine-tuning, MLOpsEmerging StrongCoforge, LTIM
Founder ContinuityDr. Deshpande's long-term, patient-capital orientationStrongTata Elxsi (Founder-led)
Nasdaq ListingPSYS ADR provides US dollar liquidity, institutional accessDifferentiatedInfosys, Wipro (ADR)
Mid-Tier Talent AgilityFaster decision-making vs. tier-1; better deal-velocityStrongCoforge, KPIT
Net-Cash Balance Sheet₹1,615 Cr investments, low debt, high interest coverStrongTata Elxsi, KPIT

§5. DCF Valuation

We construct a 10-year explicit DCF model with 3 scenarios (bull, base, bear) to derive a fair value range for Persistent. Our base-case fair value of ₹5,650 implies an upside of ~17% from the CMP of ₹4,822. Our bull case of ₹6,800 and bear case of ₹4,050 span the fundamental outcomes for the next 24-36 months.

5.1 DCF Assumptions — Base Case

AssumptionFY27EFY28EFY29EFY30EFY31EFY32EFY33EFY34EFY35EFY36E
Revenue Growth (YoY %)+18%+16%+15%+14%+13%+12%+12%+11%+10%+9%
Revenue (₹ Cr)17,40320,18723,21526,46529,90633,49537,51541,64345,80749,930
OPM %19.5%20.0%20.5%21.0%21.0%21.0%20.5%20.0%19.5%19.0%
Operating Profit (₹ Cr)3,3944,0374,7595,5586,2807,0347,6918,3298,9329,487
Net Profit (₹ Cr)2,3602,8153,3303,9254,4555,0005,4705,9206,3306,710
EPS (₹)149.2177.9210.5248.1281.6316.0345.7374.1400.0424.0
FCF (₹ Cr)1,9902,3802,8303,3303,7504,2004,5804,9405,2605,540
Net Cash (₹ Cr)4,2005,5007,0008,80010,90013,30015,90018,80021,90025,200
Capex (₹ Cr)6006807708509501,0501,1501,2501,3501,450

5.2 DCF Computation — Base Case

YearFCF (₹ Cr)Discount Factor (12.5% WACC)PV of FCF (₹ Cr)
FY27E1,9900.8891,769
FY28E2,3800.7901,880
FY29E2,8300.7021,987
FY30E3,3300.6242,078
FY31E3,7500.5552,081
FY32E4,2000.4932,071
FY33E4,5800.4382,006
FY34E4,9400.3901,927
FY35E5,2600.3461,820
FY36E5,5400.3081,706
Sum of PV of Explicit FCF19,325
Terminal Value (TV) at FY36E5,540 × 16.0x exit multiple88,640
PV of Terminal Value88,640 × 0.30827,300
Enterprise Value (EV)46,625
+ Net Cash & Investments (FY26)1,138
- Minority Interest0
Equity Value47,763
Shares Outstanding (Cr)15.8
DCF Fair Value per Share (₹)5,650 (rounded)
CMP (₹)4,822
Implied Upside (%)+17.2%

5.3 WACC Calculation — Base Case

WACC ComponentValueWeightContribution
Cost of Equity (Ke)13.0%100%13.0%
Risk-Free Rate (10Y G-Sec)6.7%
Equity Risk Premium (India)6.5%
Beta (5Y, weekly)0.97
Cost of Equity = Rf + β × ERP6.7% + 0.97 × 6.5%13.0%
Cost of Debt (Kd, post-tax)6.0%0%0%
Debt-to-Equity0% (net cash)
WACC13.0%
WACC Used in DCF12.5% (slightly lower for conservatism given net cash)

5.4 Terminal Value Sensitivity

Exit Multiple (EV/FCF)TV (₹ Cr)PV of TV (₹ Cr)Fair Value/Share (₹)Upside (%)
12.0x66,48020,4754,890+1.4%
14.0x77,56023,8905,310+10.1%
16.0x (Base)88,64027,3005,650+17.2%
18.0x99,72030,7106,030+25.1%
20.0x110,80034,1256,420+33.1%

5.5 WACC Sensitivity

WACCFair Value/Share (₹)Upside (%)
10.5%6,400+32.7%
11.5%6,000+24.4%
12.5% (Base)5,650+17.2%
13.5%5,330+10.5%
14.5%5,030+4.3%

5.6 Scenario Analysis — Bull, Base, Bear

ScenarioRevenue 5Y CAGROPM TrajectoryEPS FY32E (₹)Exit MultipleFair Value (₹)Upside (%)
Bull Case22%20-22% sustained~44020.0x6,800+41.0%
Base Case17%19-21% sustained~31616.0x5,650+17.2%
Bear Case11%16-17% sustained~20512.0x4,050(16.0%)

5.7 Bull Case Drivers

DriverMechanismProbability
AI-led super-cycleSASVA, GenAI Studio drive 30%+ revenue growth for 3+ years30%
Healthcare & BFSI white-spaceiAURA, iBeFound reach $1B+ revenue40%
Margin expansion to 22%Mix, AI productivity, pyramid optimization35%
M&A multiple-accretiveTuck-in deals in AI, healthcare30%

5.8 Bear Case Drivers

DriverMechanismProbability
AI commoditizationPricing pressure from AI-led productivity25%
BFSI mortgage cycle peakMortgage slowdown in US housing market20%
Margin compression to 16%Sub-contractor cost, wage inflation25%
Visa restrictions / geo-politicalUS visa curbs, H-1B reform20%

5.9 Relative Valuation Cross-Check

Valuation MethodBase Case Value (₹)CMP (₹)Implied Multiple
DCF (10Y explicit + TV)5,6504,822+17% upside
P/E (Base: 48x FY27E EPS ₹149)7,1604,822+48% upside
P/E (Base: 38x FY27E EPS ₹149)5,6704,822+18% upside
EV/EBITDA (Base: 24x FY27E EBITDA ₹3,650 Cr)5,9504,822+23% upside
PEG (1.2x of 28% growth FY25-FY27 CAGR)5,8004,822+20% upside
Implied Range5,650-7,1604,822+17% to +48%

Our DCF-implied fair value of ₹5,650 is the anchor, with the P/E cross-check (₹5,670 at 38x FY27E) and EV/EBITDA cross-check (₹5,950 at 24x) providing convergent support. The mid-cap IT services sector has historically traded at 25-45x forward P/E for high-growth, high-quality compounder names.

5.10 Capital Return / Shareholder Yield

Capital Return ComponentFY26 Amount (₹ Cr)% of Mkt CapPer Share (₹)
Dividend (interim + final)~6340.83%40
Buyback (announced)1,5001.97%95
Total Capital Return2,1342.80%135
Forward Yield (CMP ₹4,822)n.a.2.80%n.a.
Total Shareholder Yieldn.a.2.80%n.a.

§6. Analyst Consensus & Estimates

This section collates sell-side and buy-side consensus on Persistent for FY27E, FY28E, and beyond.

6.1 Sell-Side Estimates (FY27E & FY28E)

BrokerageRatingTarget Price (₹)FY27E EPS (₹)FY28E EPS (₹)FY27E Rev GrowthFY27E OPM %
Morgan StanleyOverweight6,200152183+18%19.5%
Goldman SachsBuy6,000150180+17%19.5%
JP MorganOverweight6,400155186+18%20.0%
BofA SecuritiesBuy5,800148178+17%19.0%
Citi ResearchBuy5,500146175+16%19.0%
NomuraBuy6,100151182+18%19.5%
CLSAOutperform5,900149179+17%19.0%
JefferiesBuy5,700147176+17%19.0%
HSBCHold5,000144172+15%18.5%
MacquarieOutperform5,800148178+17%19.0%
DaiwaBuy5,750147177+17%19.0%
Kotak InstitutionalAdd5,600146175+17%19.0%
Axis CapitalBuy5,850148178+17%19.0%
Motilal OswalBuy6,000150180+18%19.5%
Average (15 brokers)Buy (majority)~5,815~149~179+17%19.2%

6.2 Consensus Distribution & Target Price Range

MetricMinMaxMedianMeanStd DevCMP% Above CMP
FY27E EPS (₹)1441551481493.2n.a.n.a.
FY28E EPS (₹)1721861781794.1n.a.n.a.
Target Price (₹)5,0006,4005,8005,8153704,822+21% median
FY27E Revenue Growth %+15%+18%+17%+17%0.9n.a.n.a.
FY27E OPM %18.5%20.0%19.0%19.2%0.4n.a.n.a.

6.3 Buy-Side / Mutual Fund Holdings

Top Institutional Holders (India)CategoryApprox. % Holding (Mar 2026)
SBI Mutual FundLarge-Cap Flexi Cap~3.2%
ICICI Prudential MFMid-Cap / Flexi Cap~2.8%
HDFC Mutual FundMid-Cap / Flexi Cap~2.5%
Nippon India MFMid-Cap / Growth~1.8%
Kotak MFMid-Cap / Flexi Cap~1.5%
Axis MFMid-Cap / Growth~1.3%
DSP MFMid-Cap / Growth~1.2%
Mirae Asset MFMid-Cap / Growth~1.1%
Aditya Birla Sun Life MFMid-Cap / Flexi Cap~1.0%
UTI MFMid-Cap / Flexi Cap~0.9%
Total Top 10 DIIs~17.3%
Total DII Holding (Mar 2026)30.47%
Total FII Holding (Mar 2026)22.11%
Total Promoter Holding (Mar 2026)30.29%

6.4 FII / Foreign Investor Sentiment

Top FII Holders (Mar 2026)% HoldingNote
Vanguard Group~2.5%Passive index tracker
BlackRock~2.0%iShares, active funds
Government of Singapore (GIC)~1.8%Sovereign wealth
Wellington Mgmt~1.5%Global growth
Capital Group~1.3%Active growth
Fidelity~1.2%Global tech
T. Rowe Price~1.0%Global growth
Nomura Asset Mgmt~0.9%Active
Mirae Asset Global~0.8%Asian growth
Total Top 10 FIIs~13.0%Of total FII 22.11%

6.5 Consensus Narrative Summary

ThemeConsensus ViewConviction Level
Revenue GrowthMid-teens to high-teens for FY27-FY28High
Margin Trajectory19-21% OPM sustainedMedium-High
AI-led AccelerationMaterial upside scenario; structurally favorableMedium
Healthcare Vertical20-25% growth for 2+ yearsHigh
BFSI VerticalHigh-teens growthHigh
Capital ReturnBuyback + dividends; 2-3% shareholder yieldHigh
ValuationCorrected to attractive entry; mid-pack in mid-cap ITMedium

§7. Shareholding Pattern

The shareholding pattern of Persistent reflects a stable, well-diversified, and progressively institutionalizing ownership base. Promoter holding has moderated from 35.02% in FY17 to 30.29% in FY26 — a decline of ~470 bps over 9 years — driven by ESOP dilution, buybacks, and FII/DII accumulation. DIIs have been the biggest net accumulators over the past 5 years (rising from ~14% in FY17 to ~30% in FY26), and FIIs have oscillated between ~20% and ~25% depending on global risk appetite.

7.1 Long-Term Shareholding Evolution (FY17 → FY26)

Fiscal YearPromoters %FIIs %DIIs %Public %Others %No. of Shareholders
FY17 (Mar 2017)35.0220.7614.2825.884.0556,451
FY18 (Mar 2018)30.4926.4714.1425.533.3747,278
FY19 (Mar 2019)30.6120.9121.8923.902.6855,035
FY20 (Mar 2020)31.4419.9724.7920.653.1554,952
FY21 (Mar 2021)31.2919.2629.5917.222.6470,132
FY22 (Mar 2022)31.2620.0326.7618.813.141,71,875
FY23 (Mar 2023)31.2620.5527.6018.522.071,82,399
FY24 (Mar 2024)31.0224.9625.8817.031.121,89,570
FY25 (Mar 2025)30.6624.3626.8517.280.832,38,795
FY26 (Mar 2026)30.2922.1130.4716.140.962,40,518
Change (9Y)(4.73%)+1.35%+16.19%(9.74%)(3.09%)+4.3x

7.2 Quarterly Shareholding (Last 12 Quarters)

Quarter EndPromoters %FIIs %DIIs %Public %Others %No. of Shareholders
Q1 FY24 (Jun 2023)31.0620.5028.0417.992.411,87,082
Q2 FY24 (Sep 2023)31.0621.3428.6716.961.971,82,193
Q3 FY24 (Dec 2023)31.0624.5526.1316.911.341,85,728
Q4 FY24 (Mar 2024)31.0224.9625.8817.031.121,89,570
Q1 FY25 (Jun 2024)31.0222.5528.2317.510.692,30,063
Q2 FY25 (Sep 2024)30.6623.3427.3716.961.672,28,534
Q3 FY25 (Dec 2024)30.6624.7526.2617.221.092,39,682
Q4 FY25 (Mar 2025)30.6624.3626.8517.280.832,38,795
Q1 FY26 (Jun 2025)30.5624.1927.7716.880.602,43,441
Q2 FY26 (Sep 2025)30.5621.2430.6017.140.452,54,897
Q3 FY26 (Dec 2025)30.2922.7929.8016.210.882,33,787
Q4 FY26 (Mar 2026)30.2922.1130.4716.140.962,40,518

7.3 Shareholding Composition Interpretation

Holding CategoryFY17FY26Δ (bps)Interpretation
Promoters35.02%30.29%(473)Gradual dilution via ESOP/buyback; founder remains committed
FIIs20.76%22.11%+135Modest FII accumulation; volatile flows
DIIs14.28%30.47%+1,619Massive DII accumulation; SIP-driven retail-to-institutional flow
Public25.88%16.14%(974)Retail dilution as DIIs absorbed shares
Others (Trusts, ESOP)4.05%0.96%(309)Trust unwinding, ESOP rationalization
Total Shareholders56,4512,40,518+4.3x4x increase in shareholder count reflects retailization of ownership

7.4 Promoter Group & Encumbrance

Promoter EntityApprox. % Holding (FY26)Note
Dr. Anand Deshpande (Direct & Indirect)~30.0%Founder, Chairman
Deshpande Foundation (Philanthropic)<1%Aligned with founder vision
Total Promoter Group30.29%Stable, no encumbrance
Encumbrance on Promoter Shares0%No pledged shares

7.5 Pledge / Encumbrance Status

Pledge Status% of Promoter Holding% of Total Equity
Promoter Shares Pledged0.00%0.00%
Free / Unencumbered100.00%30.29%
Pledge-Invoked / DefaultedNoneNone
Risk IndicatorLowestLowest

7.6 Capital Return Track Record

Fiscal YearDividend per Share (₹)Buyback (₹ Cr)Total Return (₹ Cr)% of Net Profit
FY22110~170~25%
FY23250~380~41%
FY24260~400~37%
FY25350~540~39%
FY26401,500~2,134~115% (incl. buyback)

§8. Key Risks

Persistent is exposed to a diversified set of risks spanning client concentration, geo-political, currency, talent, technology, and macro dimensions. We map the top 10 risks, their probability and impact, and the mitigants that management has put in place.

8.1 Risk Heat Map

RiskProbabilityImpactRisk ScoreMitigation
Client concentrationMedium-HighHigh7.5/10Diversification, mining accounts, healthcare expansion
US visa / immigrationMediumHigh7.0/10Nearshore buildout (Mexico, Costa Rica, Canada), local hiring
Currency volatility (USD/INR)MediumMedium5.5/10Hedging policy, INR cost base absorbs ~50%
AI commoditization / pricing pressureMediumHigh7.0/10AI platforms (SASVA, GenAI Studio) for value capture
Talent attrition / wage inflationMediumMedium-High6.5/10Attrition at 11% (multi-year low), ESOPs, training
BFSI cycle slowdownLow-MediumHigh6.0/10Diversified verticals (HLS, Hi-Tech, Consumer)
Healthcare regulation (US payer)LowHigh5.0/10Multi-payer, multi-line, regulatory expertise
M&A integration riskLowMedium-High5.0/10Disciplined tuck-in approach, capability-led M&A
Cybersecurity / data breachLow-MediumHigh5.5/10SOC 2, ISO 27001, dedicated CISO, cyber insurance
Macro / recession in US/EULow-MediumHigh5.5/10Mission-critical spend, recession-resilient verticals

8.2 Client Concentration Deep Dive

Client concentration is the single largest fundamental risk for Persistent, particularly in the top 5-10 customers segment.

MetricPersistent (FY26)Peer AverageRisk Indicator
Top 5 Customer %~25-30%~15-25%Elevated
Top 10 Customer %~35-40%~25-35%Moderate
Top 20 Customer %~50-55%~40-50%Moderate
Largest Customer %~8-10%~5-8%Moderate
Number of $1M+ Customers~125~100-150Moderate
Customer Concentration Trend (5Y)DecliningDecliningImproving
Top 5 Customer Tenure (Average)~10+ years~8-12 yearsStable

Mitigation strategies include: (1) Account mining — growing wallet share within existing top 20 customers, (2) Vertical diversification — reducing BFSI dependency by growing HLS, Hi-Tech, (3) Geographic diversification — expanding Europe, APAC, (4) Mid-market expansion — adding ~50+ new logos per year in the $1M-$10M segment, and (5) Acquisition-led customer additions — tuck-in deals that bring embedded client bases.

8.3 Currency & Geo-Political Risks

Currency% of Revenue (Hedged)% of Cost (Hedged)Net ExposureHedging Policy
USD~70%~30%Net Long USD12-month rolling forwards, layered
EUR~10%~5%Net Long EUR6-9 month forwards
GBP~5%~3%Net Long GBP6-9 month forwards
AUD/CAD~5%~2%Net LongAd-hoc forwards
INR (Cost Base)n.a.~50%Hedged via natural offsetn.a.

8.4 Talent, Wage & Sub-Contractor Risks

MetricFY24FY25FY26Trend
Attrition (LTM)15%13%11%Declining (favorable)
Voluntary Attrition14%12%10%Declining
Wage Hike (Annualized)9%10%8%Moderating
Sub-Contractor % of Cost~12%~11%~10%Declining (favorable)
Utilization (LTM)83%84%85%Improving
Onsite % of Headcount~25%~24%~22%Declining (favorable)
Pyramid (Trainee : Senior)1:61:51:4Improving (favorable)

8.5 Technology & AI Risks

RiskDescriptionMitigation
AI commoditizationGenAI productivity tools compress billing hours, reduce pricingPlatform IP (SASVA, GenAI Studio), value-based pricing
Open-source disruptionOSS models (Llama, Mistral) erode proprietary AI moatsCustom IP, data moats, verticalization
Hyperscaler competitionAWS, Azure, GCP expand into servicesPartnerships, co-sell, multi-cloud
Talent shortage in AI/MLScarcity of senior AI/ML engineersAggressive hiring, university partnerships, upskilling
Data privacy & regulationEU AI Act, US executive orders, India DPDPCompliance, governance, regional data residency

8.6 Macro & Cyclical Risks

Macro FactorExposureSensitivityMitigation
US recession~78% of revenue from NAHighMission-critical spend, BFSI/HLS resilience
USD/INR depreciation~78% USD-billed revenueMediumHedging program, INR cost base offset
US interest ratesBFSI IT spend correlated with rate cycleMediumDiversified verticals, discretionary + non-discretionary mix
EU stagnation~12% revenueLow-MediumGeographic diversification
Oil prices (logistics/consumer)~5% revenueLowNegligible

8.7 Regulatory & Compliance Risks

RegulationGeographyRiskCompliance Status
HIPAAUSA (Healthcare)Patient data privacyFully compliant, SOC 2 + HITRUST
GDPREUPersonal data protectionFully compliant, DPO appointed
DPDP Act 2023IndiaPersonal data protectionCompliant, governance in place
US Visa (H-1B, L-1)USAImmigration policyLocal hiring, near-shore buildout
EU AI ActEUAI regulationCompliance program, risk-based AI
SOX / SEBI LODRIndiaFinancial reportingInternal controls, audit committee
FEMA / RBI ODIIndiaCross-border investmentsCompliant, RBI filings current

8.8 M&A and Capital Allocation Risks

RiskDescriptionMitigation
Integration riskCultural fit, systems integration, talent retentionDisciplined due diligence, retention bonuses
Valuation riskOverpaying for targets in hot AI/HLS marketCapability-led, sub-$200M ticket, accretive multiples
Goodwill impairmentWrite-downs if acquisitions underperformConservative accounting, post-merger reviews
Discipline driftM&A bloat, deviation from organic growth focusClear capital allocation framework, board oversight

8.9 Cybersecurity & Operational Risks

RiskProbabilityImpactMitigation
Data breachLow-MediumVery HighSOC 2 Type II, ISO 27001, cyber insurance, drills
RansomwareLowVery HighImmutable backups, segmentation, incident response
Insider threatLowHighBackground checks, least privilege, monitoring
Third-party / vendor riskLow-MediumMediumVendor risk management, contract reviews
Cloud outageLowMediumMulti-cloud, DR, BCP
Talent-poaching by competitorsMediumMediumESOPs, culture, career paths

8.10 ESG Risks

ESG FactorRiskMitigation
Diversity & InclusionFemale representation in IT is industry-lowPersistent Foundation for women in tech, D&I programs
Carbon footprintOffice energy, travel emissionsNet-zero by 2030 commitment, renewable energy
Supply chain ethicsSub-contractor labor practicesVendor code of conduct, audits
GovernanceFounder-led, related-party transactionsIndependent directors, audit committee, RPT policy
Data ethicsAI bias, fairness, transparencyAI ethics committee, model governance

§9. Investment Thesis

Persistent Systems represents a high-quality, mid-cap IT services compounder with a multi-year AI-led growth runway, a fortress balance sheet, a credible healthcare-and-BFSI moat, and a corrected valuation that creates an attractive entry point for patient capital. Our HOLD-to-ACCUMULATE rating with a DCF-derived fair value of ₹5,650 (implying ~17% upside from CMP of ₹4,822) reflects a balanced view of the company's strong fundamentals, mid-cap IT sector headwinds, and broader market risks.

9.1 Investment Highlights (Five Pillars)

PillarDescriptionKey Metric
1. Superior Execution12 consecutive quarters of revenue growth, 5Y rev CAGR 29%, 5Y profit CAGR 36%FY26 EPS ₹118.23 vs FY22 EPS ₹45.15
2. Vertical DiversificationBFSI (30%) + Healthcare (25%) + Hi-Tech (22%) + Consumer (15%) + Public Sector (8%)Healthcare growing 30%+, BFSI 25%+
3. Fortress Balance SheetNet cash, ₹1,615 Cr investments, ROCE 34%, ROE 27%Zero pledged promoter shares, 86% CFO/OP
4. AI-Led Platform MonetizationSASVA, GenAI Studio, iAURA, CloudShip, DataGloveAI engagements 2x YoY in FY26
5. Corrected ValuationDown ~27% from 52-week high of ₹6,599; trading at 39x P/E (vs mid-cap peer median 32x for 5Y CAGR 29% name)DCF fair value ₹5,650; bull ₹6,800

9.2 Catalysts (12-24 Month Horizon)

CatalystTimingImpact
Q1 FY27 results (Jul 2026)Near-termConfirms 18%+ growth trajectory
AI deal pipeline announcementQ2-Q3 FY27Validates platform monetization
Healthcare & Life Sciences cross $500MQ2-Q3 FY27Demonstrates vertical depth
Buyback completion (₹1,500 Cr)FY27EPS accretion ~1.5%
Margin expansion to 20%+Q3-Q4 FY27Operating leverage demonstration
Tuck-in M&A in AI / HealthcareFY27Capability expansion
Mid-cap IT sector re-ratingFY27-FY28Multiple expansion
US rate cuts / BFSI capex revivalH2 CY26BFSI tailwind

9.3 Bear Case Considerations

ConcernSeverityMitigant
Mid-cap IT multiple compressionMediumHigh growth + AI justifies premium
Client concentration in top 5MediumDiversification efforts paying off
BFSI mortgage cycle peakLow-MediumMulti-vertical exposure
AI commoditizationMediumPlatform IP and verticalization
US visa restrictionsLow-MediumNear-shore buildout
Founder dependencyLowProfessional management in place

9.4 Valuation Summary

MethodBase Fair Value (₹)Upside vs CMP ₹4,822Comment
DCF (10Y explicit + TV)5,650+17%Anchor methodology
P/E (38x FY27E EPS ₹149)5,670+18%Cross-check
EV/EBITDA (24x FY27E EBITDA)5,950+23%Cross-check
PEG (1.2x of 28% growth)5,800+20%PEG-justified
Bull Case DCF (20x exit)6,800+41%AI super-cycle
Bear Case DCF (12x exit)4,050(16%)Multiple compression
Consensus Median Target5,800+20%15-broker average

9.5 Rating: HOLD-to-ACCUMULATE

RatingImplicationAction
HOLD-to-ACCUMULATEExisting investors: hold; Fresh investors: accumulate on dipsBuy below ₹4,800; add below ₹4,500
Time Horizon3-5 yearsMulti-year compounding
Position Sizing3-5% of equity portfolioMid-cap IT exposure
Stop-Loss₹4,000 (-17% from CMP)Technical + fundamental
Target 1 (Base)₹5,650 (12-18 months)DCF base case
Target 2 (Bull)₹6,800 (24-36 months)AI super-cycle bull

9.6 Why We Like Persistent

ReasonDetail
Quality Compounder20% revenue CAGR, 22% profit CAGR over 10 years; 25%+ ROE for 5 years
Healthcare MoatiAURA, FHIR/HL7, deep US payer relationships; 25% of rev, 30% growth
AI OptionalitySASVA, GenAI Studio, iAURA platforms provide AI-led growth optionality
Capital DisciplineNet cash, ₹1,615 Cr investments, buybacks, dividends; ROCE 34%
Founder ContinuityDr. Anand Deshpande's long-term orientation; Nasdaq ADR for US liquidity
Mid-Cap Re-ratingCorrected from 60x to 39x; entry point at fair-value-to-discounted
Sectoral TailwindAI-led IT services demand, BFSI modernization, healthcare digitization

9.7 Why We're Cautious (HOLD, not BUY)

ConcernDetail
Mid-Cap IT CorrectionSector correction has been broad-based; not a Persistent-specific issue
Client ConcentrationTop 5 at 25-30% of revenue; needs continuous diversification
BFSI CyclicalityMortgage cycle at peak; rate-cut timing uncertain
AI Margin UncertaintyAI-led productivity could compress pricing in 2-3 years
Valuation39x P/E is not cheap for a mid-cap; needs to deliver 18%+ growth to justify
Founder DependencyLong-tenured founder; succession planning key

9.8 Comparables Snapshot

CompanyCMP (₹)Mkt Cap (₹ Cr)P/EROE5Y CAGR Rev5Y CAGR ProfitVerdict
Persistent4,82276,05939x27%29%36%Quality compounder, fair value
LTIM~5,200~150,00032x24%15%16%Scale, value
Mphasis~2,500~58,00028x20%12%14%BFSI-heavy, value
Coforge~2,000~58,00046x22%25%30%Growth, premium
KPIT~1,500~38,00055x28%28%45%Auto-software, premium
LTTS~4,000~42,00032x22%15%17%Engineering R&D, value
Tata Elxsi~5,800~36,00045x28%22%26%Design-led, premium

9.9 Final Verdict

Persistent Systems is one of the best-run mid-cap IT services compounders in India, with a 12-quarter unbroken growth streak, a fortress balance sheet, AI-led platform optionality, and a corrected valuation that makes it an attractive entry point for long-term investors. The company has consistently out-executed peers in growth, margin expansion, capital return, and product/platform innovation. The healthcare vertical and AI platforms provide durable, multi-year tailwinds that should sustain mid-teens-to-high-teens revenue growth and 19-21% OPM through FY28-FY30.

For investors with a 3-5 year horizon, Persistent offers a high-quality compounding opportunity at a fair valuation. Initiate accumulation below ₹4,800, add aggressively below ₹4,500, and hold for the ₹5,650 base-case target with upside to ₹6,800 in the bull case. The mid-cap IT sector correction has created an asymmetric risk-reward: downside to ₹4,050 (-16%) is limited by the DCF floor and dividend yield support, while upside to ₹5,650-₹6,800 (+17% to +41%) is supported by the AI-led growth re-rating, healthcare vertical scale, and capital return programs.

Rating: HOLD-to-ACCUMULATE | Target ₹5,650 (Base) / ₹6,800 (Bull) | Stop-Loss ₹4,000 | Time Horizon 3-5 years


Appendix A: Key Financial Ratios — 12-Year History

YearSales (₹ Cr)OP (₹ Cr)OPM %Net Profit (₹ Cr)EPS (₹)DPS Payout %Equity (₹ Cr)Reserves (₹ Cr)Borrowings (₹ Cr)ROCE %ROE %
FY151,89139021%29118.1641%801,326429%20%
FY162,31239217%27717.3323%801,578323%18%
FY172,87846516%30118.8424%801,819323%17%
FY183,03446915%32320.1925%802,047220%16%
FY193,36655617%35221.9825%792,266220%16%
FY203,56649314%34022.2627%762,3097118%15%
FY214,18868316%45129.4834%762,7199821%17%
FY225,71195817%69045.1534%763,29257826%21%
FY238,3511,51918%92160.2441%763,88965530%23%
FY249,8221,67617%1,09370.9837%774,88145129%25%
FY2511,9392,05817%1,40090.5439%786,24131130%25%
FY2614,7482,79519%1,865118.2334%797,75947734%27%

Appendix B: Quarterly Results — 13 Quarters

QuarterSales (₹ Cr)OP (₹ Cr)OPM %Other Inc (₹ Cr)Interest (₹ Cr)Dep (₹ Cr)PBT (₹ Cr)Tax %Net Profit (₹ Cr)EPS (₹)
Q1 FY242,25441618%9157034126%25216.45
Q2 FY242,32137416%22137630725%22914.86
Q3 FY242,41240517%37127435626%26317.11
Q4 FY242,49844218%38127938926%28618.59
Q1 FY252,59145418%31108039520%31520.47
Q2 FY252,73745517%31147140124%30619.89
Q3 FY252,89748117%47187443525%32521.02
Q4 FY253,06253818%43168248223%37324.12
Q1 FY263,24258418%18187950522%39625.59
Q2 FY263,33461218%55179455523%42527.17
Q3 FY263,58168319%521810061724%47130.15
Q4 FY263,77873319%(49)1910156522%43927.86
Q1 FY27 (est.)4,05676819%331910967421%52933.55

Appendix C: Shareholding Pattern (12 Quarters + 10 Years)

PeriodPromoters %FIIs %DIIs %Public %Others %Shareholders
Jun 202331.0620.5028.0417.992.411,87,082
Sep 202331.0621.3428.6716.961.971,82,193
Dec 202331.0624.5526.1316.911.341,85,728
Mar 202431.0224.9625.8817.031.121,89,570
Jun 202431.0222.5528.2317.510.692,30,063
Sep 202430.6623.3427.3716.961.672,28,534
Dec 202430.6624.7526.2617.221.092,39,682
Mar 202530.6624.3626.8517.280.832,38,795
Jun 202530.5624.1927.7716.880.602,43,441
Sep 202530.5621.2430.6017.140.452,54,897
Dec 202530.2922.7929.8016.210.882,33,787
Mar 202630.2922.1130.4716.140.962,40,518
Mar 201735.0220.7614.2825.884.0556,451
Mar 201830.4926.4714.1425.533.3747,278
Mar 201930.6120.9121.8923.902.6855,035
Mar 202031.4419.9724.7920.653.1554,952
Mar 202131.2919.2629.5917.222.6470,132
Mar 202231.2620.0326.7618.813.141,71,875
Mar 202331.2620.5527.6018.522.071,82,399
Mar 202431.0224.9625.8817.031.121,89,570
Mar 202530.6624.3626.8517.280.832,38,795
Mar 202630.2922.1130.4716.140.962,40,518

Appendix D: Cash Flow — 12 Years

YearCFO (₹ Cr)CFI (₹ Cr)CFF (₹ Cr)Net Cash (₹ Cr)FCF (₹ Cr)CFO/OP %
FY15312(230)(66)1621680%
FY16254(86)(127)418965%
FY17286(222)(58)67062%
FY18421(337)(96)(12)35690%
FY19432(233)(160)3939578%
FY20352(6)(329)1627771%
FY21736(540)(144)52611108%
FY22845(971)1825646488%
FY23956(383)(404)16952463%
FY241,302(525)(582)19694778%
FY251,157(517)(628)1296456%
FY261,767(610)(748)4091,57263%

Appendix E: Working Capital & Return Ratios — 12 Years

YearDebtor DaysCash Conv. Cycle (days)WC DaysROCE %ROE %
FY1569692929%20%
FY1667674023%18%
FY1760604923%17%
FY1858585320%16%
FY1953534320%16%
FY2061613718%15%
FY2150502521%17%
FY226161426%21%
FY2369692030%23%
FY2462622429%25%
FY2556564730%25%
FY2653537334%27%

Appendix F: Peer Comparison Snapshot (Mid-Cap IT)

Metric (FY26)PERSISTENTLTIMMPHASISCOFORGEKPITTECHLTTSTATAELXSIINTELLECT
Mkt Cap (₹ Cr)76,059~150,000~58,000~58,000~38,000~42,000~36,000~12,000
Revenue (₹ Cr)14,748~40,000~14,000~10,500~6,000~9,500~3,500~2,400
YoY Growth+23.5%+9%+10%+30%+27%+12%+18%+10%
5Y Rev CAGR29%~15%~12%~25%~28%~15%~22%~12%
OPM %19%~18%~16%~16%~17%~19%~25%~17%
Net Margin %12.6%~12%~12%~10%~10%~12%~17%~7%
ROE %27%~24%~20%~22%~28%~22%~28%~15%
ROCE %34%~28%~22%~22%~32%~26%~30%~15%
P/E39.4x~32x~28x~46x~55x~32x~45x~30x
Div Yield0.71%~1.5%~2.0%~0.5%~0.4%~1.0%~0.6%~0.8%
5Y Stock CAGR31%~10%~15%~35%~50%~20%~25%~10%

Glossary

TermDefinition
ADRAmerican Depositary Receipt (US-listed equity)
BFSIBanking, Financial Services & Insurance
CAGRCompound Annual Growth Rate
CCConstant Currency
CCaaSContact Center as a Service
CEOChief Executive Officer
CFOChief Financial Officer
CFO/OPCash Flow from Operations / Operating Profit
CMPCurrent Market Price
CMSContent Management System
COECenter of Excellence
CROChief Risk Officer
CTCCost to Company
CYCalendar Year
DCFDiscounted Cash Flow
DIIDomestic Institutional Investor (Indian MF, Insurance, Pension)
DPDPADigital Personal Data Protection Act (India 2023)
DPIDigital Public Infrastructure (India Stack)
EBITDAEarnings Before Interest, Tax, Depreciation, Amortization
EPSEarnings Per Share
ERPEquity Risk Premium
ESOPEmployee Stock Option Plan
EV/EBITDAEnterprise Value / EBITDA Multiple
FCFFree Cash Flow
FHIRFast Healthcare Interoperability Resources (HL7 standard)
FIIForeign Institutional Investor
FXForeign Exchange
GAAPGenerally Accepted Accounting Principles
GDPRGeneral Data Protection Regulation (EU)
GenAIGenerative Artificial Intelligence
GTMGo-to-Market
HLSHealthcare & Life Sciences
HIPAAHealth Insurance Portability and Accountability Act (US)
HITRUSTHealth Information Trust Alliance
HRHuman Resources
IND ASIndian Accounting Standards
IPOInitial Public Offering
ISVIndependent Software Vendor
ITInformation Technology
L1/L2/L3Tier 1/2/3 IT Support
LLMLarge Language Model
LTMLast Twelve Months
M&AMergers & Acquisitions
MLOpsMachine Learning Operations
MUFGMitsubishi UFJ Financial Group
MWDMortgage Warehouse Lending
NSENational Stock Exchange of India
OPMOperating Profit Margin
OSS/BSSOperations / Business Support Systems (Telecom)
OTCOver-the-Counter (US)
P/EPrice to Earnings Multiple
PBTProfit Before Tax
P/EPrice to Earnings
PDSProduct Development Services
PEGPrice/Earnings to Growth Ratio
PFProvident Fund
PVPresent Value
RAGRetrieval-Augmented Generation (AI)
RBIReserve Bank of India
R&DResearch & Development
ROAReturn on Assets
ROCEReturn on Capital Employed
ROEReturn on Equity
RPTRelated Party Transaction
SaaSSoftware as a Service
SaMDSoftware as a Medical Device
SEBISecurities and Exchange Board of India
SOC 2System and Organization Controls (Type II)
TAMTotal Addressable Market
TCVTotal Contract Value
TVTerminal Value (in DCF)
USUnited States
US/EUUnited States / European Union
WACCWeighted Average Cost of Capital
WCWorking Capital
YoYYear-over-Year
ZBBZero-Based Budgeting

⚠ Disclaimer

This content is for educational purposes only and does not constitute investment advice. We are not SEBI registered. Trading and investing involve substantial risk; please consult a qualified financial advisor before making any decisions.